Cheng Du Sheng Nuo Biotec Co. Ltd. A (688117) - Total Liabilities

Latest as of September 2025: CN¥877.24 Million CNY ≈ $128.37 Million USD

Based on the latest financial reports, Cheng Du Sheng Nuo Biotec Co. Ltd. A (688117) has total liabilities worth CN¥877.24 Million CNY (≈ $128.37 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Cheng Du Sheng Nuo Biotec Co. Ltd. A to track the company's year-over-year net asset growth rate.

Cheng Du Sheng Nuo Biotec Co. Ltd. A - Total Liabilities Trend (2017–2024)

This chart illustrates how Cheng Du Sheng Nuo Biotec Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data. See 688117 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Cheng Du Sheng Nuo Biotec Co. Ltd. A Competitors by Total Liabilities

The table below lists competitors of Cheng Du Sheng Nuo Biotec Co. Ltd. A ranked by their total liabilities.

Company	Country	Total Liabilities
Sinotherapeutics Inc. A SHG:688247	China	CN¥145.56 Million
Taiwan Sakura Corp TW:9911	Taiwan	NT$4.04 Billion
ForFarmers NV AS:FFARM	Netherlands	€672.00 Million
MNRB Holdings Bhd KLSE:6459	Malaysia	RM10.34 Billion
Vulcan Steel Ltd AU:VSL	Australia	AU$787.93 Million
Ningbo Zhongbai Co Ltd SHG:600857	China	CN¥64.61 Million
goeasy Ltd TO:GSY	Canada	CA$4.97 Billion
Thai Stanley Electric Public Company Limited BK:STANLY	Thailand	฿2.52 Billion

Liability Composition Analysis (2017–2024)

This chart breaks down Cheng Du Sheng Nuo Biotec Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688117 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.46	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.85	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.46	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cheng Du Sheng Nuo Biotec Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cheng Du Sheng Nuo Biotec Co. Ltd. A (2017–2024)

The table below shows the annual total liabilities of Cheng Du Sheng Nuo Biotec Co. Ltd. A from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥729.58 Million ≈ $106.76 Million	+67.48%
2023-12-31	CN¥435.63 Million ≈ $63.75 Million	+54.88%
2022-12-31	CN¥281.27 Million ≈ $41.16 Million	+64.03%
2021-12-31	CN¥171.48 Million ≈ $25.09 Million	+10.34%
2020-12-31	CN¥155.41 Million ≈ $22.74 Million	+9.09%
2019-12-31	CN¥142.46 Million ≈ $20.85 Million	-5.59%
2018-12-31	CN¥150.90 Million ≈ $22.08 Million	+41.74%
2017-12-31	CN¥106.46 Million ≈ $15.58 Million	--

About Cheng Du Sheng Nuo Biotec Co. Ltd. A

SHG:688117 China Drug Manufacturers - Specialty & Generic

Market Cap

$564.25 Million

CN¥3.86 Billion CNY

Market Cap Rank

#11581 Global

#3271 in China

Share Price

CN¥24.50

Change (1 day)

+2.98%

52-Week Range

CN¥21.44 - CN¥46.10

All Time High

CN¥48.78